Daily Papers

Traditional agentic workflows rely on external prompts to manage interactions with tools and the environment, which limits the autonomy of reasoning models. We position Large Agent Models (LAMs) that internalize the generation of Chain-of-Action (CoA), enabling the model to autonomously decide when and how to use external tools. Our proposed AutoCoA framework combines supervised fine-tuning (SFT) and reinforcement learning (RL), allowing the model to seamlessly switch between reasoning and action while efficiently managing environment interactions. Main components include step-level action triggering, trajectory-level CoA optimization, and an internal world model to reduce real-environment interaction costs. Evaluations on open-domain QA tasks demonstrate that AutoCoA-trained agent models significantly outperform ReAct-based workflows in task completion, especially in tasks that require long-term reasoning and multi-step actions. Code and dataset are available at https://github.com/ADaM-BJTU/AutoCoA

We present a Conversational Chain-of-Action (Conv-CoA) framework for Open-domain Conversational Question Answering (OCQA). Compared with literature, Conv-CoA addresses three major challenges: (i) unfaithful hallucination that is inconsistent with real-time or domain facts, (ii) weak reasoning performance in conversational scenarios, and (iii) unsatisfying performance in conversational information retrieval. Our key contribution is a dynamic reasoning-retrieval mechanism that extracts the intent of the question and decomposes it into a reasoning chain to be solved via systematic prompting, pre-designed actions, updating the Contextual Knowledge Set (CKS), and a novel Hopfield-based retriever. Methodologically, we propose a resource-efficiency Hopfield retriever to enhance the efficiency and accuracy of conversational information retrieval within our actions. Additionally, we propose a conversational-multi-reference faith score (Conv-MRFS) to verify and resolve conflicts between retrieved knowledge and answers in conversations. Empirically, we conduct comparisons between our framework and 23 state-of-the-art methods across five different research directions and two public benchmarks. These comparisons demonstrate that our Conv-CoA outperforms other methods in both the accuracy and efficiency dimensions.

Drug discovery typically consists of multiple steps, including identifying a target protein key to a disease's etiology, validating that interacting with this target could prevent symptoms or cure the disease, discovering a small molecule or biologic therapeutic to interact with it, and optimizing the candidate molecule through a complex landscape of required properties. Drug discovery related tasks often involve prediction and generation while considering multiple entities that potentially interact, which poses a challenge for typical AI models. For this purpose we present MAMMAL - Molecular Aligned Multi-Modal Architecture and Language - a method that we applied to create a versatile multi-task foundation model ibm/biomed.omics.bl.sm.ma-ted-458m that learns from large-scale biological datasets (2 billion samples) across diverse modalities, including proteins, small molecules, and genes. We introduce a prompt syntax that supports a wide range of classification, regression, and generation tasks. It allows combining different modalities and entity types as inputs and/or outputs. Our model handles combinations of tokens and scalars and enables the generation of small molecules and proteins, property prediction, and transcriptomic lab test predictions. We evaluated the model on 11 diverse downstream tasks spanning different steps within a typical drug discovery pipeline, where it reaches new SOTA in 9 tasks and is comparable to SOTA in 2 tasks. This performance is achieved while using a unified architecture serving all tasks, in contrast to the original SOTA performance achieved using tailored architectures. The model code and pretrained weights are publicly available at https://github.com/BiomedSciAI/biomed-multi-alignment and https://huggingface.co/ibm/biomed.omics.bl.sm.ma-ted-458m.